Takeda announces launch of Framework to help support patient access to life-extending combination treatments

February 25, 2025
Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access

The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …

Recce Pharmaceuticals reports positive phase 2 data for skin infection drug

February 17, 2025
Research and Development Recce, Skin, diabetes, skin, skin infections

Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment …

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025
Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …

Cardinal Healthโ€™s Kangaroo OMNIโ„ข Enteral Feeding Pump to launch in new international markets in 2025

February 6, 2025
Sales and Marketing Kangaroo, enteral, feeding pump

The next generation Kangaroo OMNIโ„ข enteral feeding pump delivers nutrition and hydration from hospital to home. DUBLIN, Ireland, Feb.4, 2025 …

1200px-european_flag_in_karlskrona_2011

European Commission launches new Biotech and Biomanufacturing Hub

February 3, 2025
Research and Development Biomanufacturing, Corporate, European Commission, Hub, european union

The European Commission has announced the opening of a new Biotech and Biomanufacturing Hub, supporting start-ups and small- to medium-sized …

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors

February 3, 2025
Business Services, Conferences Air France KLM Martinair Cargo ., Amsterdam Airport Schiphol, Corporate, DHL Global Forwarding, FlyPharma Conferences, logistics

FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, …

Prenatal care could be revolutionised suggests studies from BrightHeart

January 31, 2025
Research and Development AI, BrightHeart, FDA, Obstetrics & Gynaecology, prenatal, studies

Private medical device and artificial intelligence (AI)-led company, BrightHeart, has revealed two studies which show an improvement to pre-natal care …

CANDOR Bioscience acquired by Medix Biochemica

January 31, 2025
Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics

CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …

MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients

January 30, 2025
Research and Development MHRA, Oncology, approvals, multiple myeloma, rare diseases

The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in combination to treat multiple myeloma …

Bayer UK Launches New CanesMenoยฎ Educational Hub and Product Range to Transform Menopause Support

January 30, 2025
Medical Communications

29 January 2025 โ€“ Reading, UK โ€“ Bayer Consumer Health is entering the menopause category for the first time in …

NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera

January 29, 2025
Sales and Marketing Duchenne Muscular Dystrophy, EC, EMA, FDA, Santhera Pharmaceuticals, positive

Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence (NICE) for AGAMREE (vamorolone) to …

Positive topline results announced in phase 2 Alcohol Use Disorder study

January 29, 2025
Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025
Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …

handshake2

Jรฉrรดme Berger announced as strategy and finance executive at Vect-Horus

January 28, 2025
appointment, private biotechnology company

Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jรฉrรดme Berger to its board of …

Research collaboration announced between Oxford University and GSK

January 27, 2025
Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

January 23, 2025
Paris, Pharmapack 2025, Winners, pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexyโ„ข reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilockโ„ข …

Combination first-in-line treatment approved for patients with non-small cell lung cancer

January 23, 2025
Research and Development J&J Innovative Medicine, Oncology, approval, non-small cell lung cancer

Johnson & Johnson Innovative Medicine  have announced that the European Commission (EC) has approved a marketing authorisation for the combination …

Pharmapack Europe the โ€˜Heart of Pharmaโ€™ Start-ups in Paris

January 23, 2025
Medical Communications, Public Relations Heart of Pharma, Paris, pharmapack

Six start-ups bestowed with new โ€˜heart of pharmaโ€™ commendation in recognition of innovations advancing drug delivery and packaging 22 January …

Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first projectย 

January 22, 2025
Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project

Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …

First patients treated with HEMGENIXยฎ (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark

January 21, 2025
Sales and Marketing CSL, Denmark, genetic, haemophilia, treatment

21 January 2025 โ€“ Copenhagen, Denmark โ€“ CSL Behring Denmark today announced that the first Danish patients with haemophilia B …

The Gateway to Local Adoption Series

Latest content